Veraxa Biotech AG (NASDAQ:VRXA)
| Market Cap | 169.69M-90.2% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 141.41M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 747,176 |
| Open | 1.16 |
| Previous Close | 1.08 |
| Day's Range | 1.10 - 1.32 |
| 52-Week Range | 1.04 - 27.36 |
| Beta | 0.26 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Veraxa Biotech AG has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About VRXA
Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company was founded in 2021 and is based in Heidelberg, Germany.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$VRXA stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in VRXA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by VRXA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
VRXA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New VRXA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to VRXA from public contracts
Source: USAspending.gov
VRXA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from VRXA’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score